AMANDA ROSEN: Open Payments
NPI 1508535337 · CLAYTON, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$530 in 24 payments from 11 companies in 2025. Trend: 2023 $254 · 2024 $505 · 2025 $530
Food & beverage: $530
| Company | Payments | Amount |
|---|---|---|
| GlaxoSmithKline, LLC. | 4 | $128 |
| Madrigal Pharmaceuticals | 3 | $108 |
| ABBVIE INC. | 3 | $56 |
| Lilly USA, LLC | 3 | $50 |
| Phathom Pharmaceuticals, Inc. | 3 | $43 |
| Novo Nordisk Inc | 2 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $34 |
| Exact Sciences Corporation | 1 | $21 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $21 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $18 |
Products named: AREXVY, REZDIFFRA, VRAYLAR, MOUNJARO, VOQUEZNA, AIRSUPRA, The Cologuard Plus Collection Kit, XIFAXAN.
Industry payments across NY — which companies pay providers there.
